TAKE NOTICE that the Annual General Meeting of Shareholders of the Company will be held at the time, date and place specified below:
Time: 11.00 am (Melbourne time)
Date: Wednesday, 22 July 2020
Place: Online only
Read the Notice of Annual General Meeting and Explanatory Memorandum.
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has
Key Highlights: Manufacturing and Testing of MagSense® HER2 Imaging Agent Completed, Paving Way for IND Submission Q1 2026 Wayne State University Collaboration for MRI Optimization
Positive Final Results of Wayne State Collaboration Drives Completion of Phase 2 Study Protocol for IND Submission to FDA in December Key Highlights: MagSense® HER2
We’re on a mission to make cancer more detectable.